查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
至2030年多重檢測市場預測：按產品類型、技術、應用、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1383379

至2030年多重檢測市場預測：按產品類型、技術、應用、最終用戶和地區進行的全球分析

Multiplex Assays Market Forecasts to 2030 - Global Analysis By Product, Type, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球多重檢測市場規模將達到 38 億美元，預計到2030年將達到 79 億美元，預測期內CAGR為 10.8%。

多重測定是一種實驗室技術，可同時測量一個生物樣本中的多種分析物，例如蛋白質、核酸或其他分子。這種實驗室技術廣泛應用於生物學、醫學和診斷的許多領域，使研究人員能夠從單一樣本中提取更多資訊。多重檢測技術經常用於醫院、臨床實驗室、研究機構、製藥公司和生物技術公司。

根據世界衛生組織2023年7月發布的報告，估計每年新增感染者3.74億，四分之一的人可以治愈，15 歲至 49 歲之間的生殖器感染者中有超過 5 億人感染了單純皰疹病毒（HSV 或皰疹）。

多重檢測技術的進展

PCR 和免疫測量等多重分析徹底改變了研究和診斷。這些創新方法透過識別一個樣品中的多種分析物來節省時間和金錢。免疫測量使用抗體來識別和定量目標分析物。多重免疫測量可評估單一樣本中的多種生物標記、細胞激素或分析物。這可以節省時間和金錢，同時增加對疾病的了解。螢光的引子和探針可以在一次反應中擴增和檢測多個目標序列，實現多種分析物的高通量篩選。

高成本

多重檢測設備的初始投資較高。儘管有長期的節省和效益，但初始投資成本可能會在一定程度上抑制多重檢測的小規模使用。所需試劑的變動成本及其供應商固定的成本增加了總支出。此外，維護和保險、實驗室監督和管理費用（包括公用事業、空間和管理）都是額外成本。因此，高設備成本是限制多重偵測廣泛普及的主要因素。

製藥和生物技術產業的擴張

多重檢測市場的成長主要受到製藥和生物技術產業擴張的推動。先進的診斷工具在支持這些行業的研究、藥物開發和臨床應用方面發揮著非常重要的作用。此外，多重檢測對於這兩個領域都是不可或缺的，因為它們允許在一個樣本中同時分析多個生物標記。由於這些特徵，多重檢測在各種生物技術和製藥應用中變得越來越重要。

資料安全問題

資料安全問題為多重檢測市場帶來了重大風險。多重檢測中資料的資料的敏感度增加了詐欺的存取、洩漏和濫用的風險。醫療和研究領域有嚴格的資料保護條例，需要強而有力的網路安全措施。研究和資料的潛在洩漏資料市場接受度並損害相關人員的信任。因此，市場的成長受到阻礙。

COVID-19 的影響

市場受到了 COVID-19 的重大積極影響。在此大流行期間，使用了 SARS-CoV-2 等多重檢測方法來診斷新冠病毒。疫情期間，隨著世界各地的衛生系統爭先恐後地擴大檢測能力和提高效率，對多重檢測的需求激增。 FDA已向多家公司授予批准，進一步為市場拓展鋪路。在大流行期間，多重檢測製造商推出了許多檢測方法，提高了市場成長率。

流式細胞儀領域預計將在預測期內成為最大的領域

流式細胞儀領域估計佔據最大佔有率。流式細胞儀在速度、靈敏度和準確性方面具有顯著優勢，允許在單細胞層級同時分析多個參數。流式細胞儀領域由於其能夠產生大量資料並提供高通量分析而成為市場領先的技術。隨著對個人化醫療和精準疾病診斷的需求不斷增加，客戶擴大選擇流式細胞儀等能夠提供全面、可靠結果的儀器。預計未來幾年，多重檢測市場將以流式細胞儀領域最快的速度成長。

預計研發領域在預測期內CAGR最高

多重檢測經常用於研究環境中，以闡明複雜的生物過程、疾病機制、藥物開發等。研發部門引領市場，因為他們可以為科學研究和醫藥創新提供關鍵資料。複雜疾病數量的不斷增加以及對尖端治療解決方案的需求推動對產生新治療方法的研發計劃的投資增加。研究和開發領域預計將在多重檢測市場中成長最快。

比最大的地區

由於多重檢測產品和服務的高採用率以及新興市場資本利得的顯著成長，北美在預測期內獲得了最大的市場佔有率佔有率。最近推出的產品和先進的醫療保健系統也有助於該地區的市場擴張。此外，大公司的存在、研發設施、高醫療旅遊和高購買力也有助於市場擴張。

複合CAGR最高的地區：

由於患有感染疾病和慢性病的人數增加、人們對使用多重檢測產品和服務的好處的認知不斷提高以及中國等人口大國購買力的不斷提高，亞太地區將在預測期內繼續成長預計在此期間將出現獲利成長。此外，由於新的主要參與者進入市場、人均支出增加以及政府措施不斷增加，該地區的市場成長。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計/預測/CAGR（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球多重檢測市場：依產品

  • 介紹
  • 裝置
  • 消耗品
  • 軟體和服務

第6章 全球多重檢測市場：依類型

  • 介紹
  • 基於蛋白質的多重檢測
    • 基於微珠的蛋白質檢測
    • 平面蛋白質測定
    • 其他蛋白質多重檢測
  • 核酸多重檢測
    • 基於微珠的核酸檢測
    • 平面核酸測定
    • 其他核酸多重檢測
  • 基於細胞的多重檢測

第7章 全球多重檢測市場：依技術分類

  • 介紹
  • 發光
  • 流式細胞儀
  • 多重即時 PCR
  • 螢光偵測
  • 其他技術

第8章 全球多重檢測市場：依應用

  • 介紹
  • 研究與開發
    • 生物標記的發現與檢驗
    • 藥物研發發現與開發
  • 臨床診斷
    • 感染疾病
    • 心血管疾病
    • 癌症
    • 自體免疫疾病
    • 代謝及內分泌疾病
    • 神經系統疾病
    • 其他臨床診斷

第9章 全球多重檢測市場：依最終用戶分類

  • 介紹
  • 醫院和診斷實驗室
  • 製藥和生物技術公司
  • 學術機構
  • 其他最終用戶

第10章 全球多重檢測市場：依地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第11章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Siemens Healthineers
  • Danaher Corporation
  • Hoffmann-La Roche
  • Biomerieux
  • Bio-Rad Laboratories
  • Sekisui Medical
  • Buhlmann Laboratories
  • Randox Laboratories
  • Merck Sharp & Dohme Corp
  • Illumina Inc
  • Qiagen
  • Abcam plc
  • Agilent Technologies
  • Meso Scale Diagnostics LLC
Product Code: SMRC24229

According to Stratistics MRC, the Global Multiplex Assays Market is accounted for $3.8 billion in 2023 and is expected to reach $7.9 billion by 2030 growing at a CAGR of 10.8% during the forecast period. A multiplex assay is a lab technique that measures several analytes, such as proteins, nucleic acids, or other molecules, simultaneously in a single biological sample. This lab technique is widely used in many areas of biology, medicine, and diagnostics and enables researchers to extract more information from a single sample. Hospitals, clinical laboratories, research facilities, and pharmaceutical and biotechnological companies all frequently use the multiplex assay technique.

According to the report published by WHO in July 2023, each year there are an estimated 374 million new infections with 1 of 4 curable, more than 500 million people 15-49 years of age are estimated to have a genital infection with herpes simplex virus (HSV or herpes).

Market Dynamics:

Driver:

Advances in multiplex assay technologies

Multiplex assays have revolutionized research and diagnosis, such as PCR and immunoassays. These innovative methods save time and money by identifying numerous analytes in a single sample. Antibodies are used in immunoassays to identify and quantify target analytes. With multiplex immunoassays, numerous biomarkers, cytokines, or analytes are assessed in a single sample. This enhances knowledge of illness while saving time and money. Fluorescently tagged primers and probes may amplify and detect multiple target sequences in a single reaction, enabling high-throughput screening of multiple analytes.

Restraint:

High cost

The initial investment in multiplex assay equipment is high. Despite long-term savings and advantages, the initial investment costs may restrain the small-scale use of multiplex assays to a certain extent. The variable costs of the reagents needed and those fixed by the suppliers thereof add to the overall expenditure. Furthermore, maintenance and insurance, laboratory supervision, and overhead costs (including utilities, space, and administration) are also additional expenses. As a result, high instrument costs are a major factor limiting the wider adoption of multiplex assays.

Opportunity:

Expansion of the pharmaceutical and biotechnology industries

The growth of the multiplex assay market has been significantly fuelled by the expansion of the pharmaceutical and biotechnology industries. Advanced diagnostic tools play a critical role in supporting research, drug development, and clinical applications in these industries. Moreover, because multiplex assays allow for the simultaneous analysis of multiple biomarkers in a single sample, they are essential to both fields. Multiplex assays are becoming more and more essential in a variety of biotechnology and pharmaceutical applications due to this capability.

Threat:

Data security concerns

Data security concerns pose significant risks to the multiplex assay market. The risk of unauthorised access, breaches, or misuse is elevated due to the sensitive nature of the clinical and biological data used in multiplex assessments. Stringent data protection regulations in the healthcare and research sectors require robust cyber security measures. The potential harm to research and patient data hinders market acceptance and erodes confidence among stakeholders. Thus, market growth is hampered.

COVID-19 Impact

The market has been greatly and positively impacted by COVID-19. Multiplex assays, such as the SARS-CoV-2 assay, were used to diagnose COVID during this pandemic phase. During the pandemic, the demand for multiplex assays skyrocketed as healthcare systems worldwide scrambled to expand testing capabilities and improve efficiency. The FDA has granted approval to a number of companies, which has further paved the way for the market's expansion. During the pandemic, multiplex assay manufacturers have introduced a number of assays, which has increased the market's growth rate.

The flow cytometry segment is expected to be the largest during the forecast period

The flow cytometry segment is estimated to hold the largest share. Flow cytometry provides major advantages in terms of speed, sensitivity, and accuracy and allows for the simultaneous analysis of multiple parameters at the single-cell level. The flow cytometry segment is a leading technology in the market because of its capacity to generate large amounts of data and offer high-throughput analysis. Customers are more likely to choose devices like flow cytometry that can deliver thorough and dependable results due to the rising demand for personalized medicine and precise disease diagnosis. In the upcoming years, the multiplex assay market is anticipated to grow at the fastest rate in the flow cytometry segment.

The research & development segment is expected to have the highest CAGR during the forecast period

The research & development segment is anticipated to have lucrative growth during the forecast period Multiplex assays are frequently used in research settings to shed light on intricate biological processes, illness mechanisms, and medication development. The research and development sector is a market leader because it can supply important data for scientific investigations and pharmaceutical innovations. Customers are increasingly willing to invest in research and development projects that can result in novel treatments due to the rising incidence of complex diseases and the demand for cutting-edge therapeutic solutions. In the multiplex assay market, the research and development segment is anticipated to grow at the quickest rate.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to the high rate of adoption of multiplex assay goods and services as well as the notable rise in capital income in developed nations. The region's access to recently released goods and sophisticated healthcare systems also contribute to the market's expansion. Additionally, the market is expanding due to the presence of major players, R&D facilities, high levels of medical tourism, and strong purchasing power.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, due to the rise in the number of people with infectious and chronic illnesses, the growing awareness of the benefits of using multiplex assay goods and services, and the rising purchasing power of highly populated nations like China and India. Additionally, the region's market is growing because of things like new major players entering the market, rising per capita spending, and more government initiatives to improve the region's healthcare infrastructure.

Key players in the market

Some of the key players in the Multiplex Assays Market include: Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, Danaher Corporation, Hoffmann-La Roche, Biomerieux, Bio-Rad Laboratories, Sekisui Medical, Buhlmann Laboratories, Randox Laboratories, Merck Sharp & Dohme Corp, Illumina Inc, Qiagen, Abcam plc, Agilent Technologies and Meso Scale Diagnostics LLC.

Key Developments:

In July 2023, QIAGEN announced that the expansion of its digital PCR (dPCR) offering for the development of cell and gene therapies in the biopharma industry.

In June 2023, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A., a Warsaw, Poland, based developer of the PCR ONE technology for rapid, automated detection of infections via highly multiplexed PCR assays.

Products Covered:

  • Instruments
  • Consumables
  • Software & Services

Types Covered:

  • Protein Based Multiplex Assays
  • Nucleic Acid Multiplex Assays
  • Cell-based Multiplex Assays

Technologies Covered:

  • Luminescence
  • Flow Cytometry
  • Multiplex Real-Time PCR
  • Fluorescence Detection
  • Other Technologies

Applications Covered:

  • Research & Development
  • Clinical Diagnostics

End Users Covered:

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Multiplex Assays Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Consumables
  • 5.4 Software & Services

6 Global Multiplex Assays Market, By Type

  • 6.1 Introduction
  • 6.2 Protein Based Multiplex Assays
    • 6.2.1 Bead-Based Protein Assays
    • 6.2.2 Planar Protein Assays
    • 6.2.3 Other Protein Multiplex Assays
  • 6.3 Nucleic Acid Multiplex Assays
    • 6.3.1 Bead-Based Nucleic Acid Assays
    • 6.3.2 Planar Nucleic Acid Assays
    • 6.3.3 Other Nucleic Acid Multiplex Assays
  • 6.4 Cell-based Multiplex Assays

7 Global Multiplex Assays Market, By Technology

  • 7.1 Introduction
  • 7.2 Luminescence
  • 7.3 Flow Cytometry
  • 7.4 Multiplex Real-Time PCR
  • 7.5 Fluorescence Detection
  • 7.6 Other Technologies

8 Global Multiplex Assays Market, By Application

  • 8.1 Introduction
  • 8.2 Research & Development
    • 8.2.1 Biomarker Discovery & Validation
    • 8.2.2 Drug Discovery & Development
  • 8.3 Clinical Diagnostics
    • 8.3.1 Infectious Diseases
    • 8.3.2 Cardiovascular Diseases
    • 8.3.3 Cancer
    • 8.3.4 Autoimmune Diseases
    • 8.3.5 Metabolism & Endocrinology Disorders
    • 8.3.6 Nervous System Disorders
    • 8.3.7 Other Clinical Diagnostics

9 Global Multiplex Assays Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Diagnostic Laboratories
  • 9.3 Pharmaceutical & Biotechnology Companies
  • 9.4 Academic Institutes
  • 9.5 Other End Users

10 Global Multiplex Assays Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Thermo Fisher Scientific
  • 12.3 Siemens Healthineers
  • 12.4 Danaher Corporation
  • 12.5 Hoffmann-La Roche
  • 12.6 Biomerieux
  • 12.7 Bio-Rad Laboratories
  • 12.8 Sekisui Medical
  • 12.9 Buhlmann Laboratories
  • 12.10 Randox Laboratories
  • 12.11 Merck Sharp & Dohme Corp
  • 12.12 Illumina Inc
  • 12.13 Qiagen
  • 12.14 Abcam plc
  • 12.15 Agilent Technologies
  • 12.16 Meso Scale Diagnostics LLC

List of Tables

  • Table 1 Global Multiplex Assays Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Multiplex Assays Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Multiplex Assays Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Multiplex Assays Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 5 Global Multiplex Assays Market Outlook, By Software & Services (2021-2030) ($MN)
  • Table 6 Global Multiplex Assays Market Outlook, By Type (2021-2030) ($MN)
  • Table 7 Global Multiplex Assays Market Outlook, By Protein Based Multiplex Assays (2021-2030) ($MN)
  • Table 8 Global Multiplex Assays Market Outlook, By Bead-Based Protein Assays (2021-2030) ($MN)
  • Table 9 Global Multiplex Assays Market Outlook, By Planar Protein Assays (2021-2030) ($MN)
  • Table 10 Global Multiplex Assays Market Outlook, By Other Protein Multiplex Assays (2021-2030) ($MN)
  • Table 11 Global Multiplex Assays Market Outlook, By Nucleic Acid Multiplex Assays (2021-2030) ($MN)
  • Table 12 Global Multiplex Assays Market Outlook, By Bead-Based Nucleic Acid Assays (2021-2030) ($MN)
  • Table 13 Global Multiplex Assays Market Outlook, By Planar Nucleic Acid Assays (2021-2030) ($MN)
  • Table 14 Global Multiplex Assays Market Outlook, By Other Nucleic Acid Multiplex Assays (2021-2030) ($MN)
  • Table 15 Global Multiplex Assays Market Outlook, By Cell-based Multiplex Assays (2021-2030) ($MN)
  • Table 16 Global Multiplex Assays Market Outlook, By Technology (2021-2030) ($MN)
  • Table 17 Global Multiplex Assays Market Outlook, By Luminescence (2021-2030) ($MN)
  • Table 18 Global Multiplex Assays Market Outlook, By Flow Cytometry (2021-2030) ($MN)
  • Table 19 Global Multiplex Assays Market Outlook, By Multiplex Real-Time PCR (2021-2030) ($MN)
  • Table 20 Global Multiplex Assays Market Outlook, By Fluorescence Detection (2021-2030) ($MN)
  • Table 21 Global Multiplex Assays Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 22 Global Multiplex Assays Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Multiplex Assays Market Outlook, By Research & Development (2021-2030) ($MN)
  • Table 24 Global Multiplex Assays Market Outlook, By Biomarker Discovery & Validation (2021-2030) ($MN)
  • Table 25 Global Multiplex Assays Market Outlook, By Drug Discovery & Development (2021-2030) ($MN)
  • Table 26 Global Multiplex Assays Market Outlook, By Clinical Diagnostics (2021-2030) ($MN)
  • Table 27 Global Multiplex Assays Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 28 Global Multiplex Assays Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 29 Global Multiplex Assays Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 30 Global Multiplex Assays Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
  • Table 31 Global Multiplex Assays Market Outlook, By Metabolism & Endocrinology Disorders (2021-2030) ($MN)
  • Table 32 Global Multiplex Assays Market Outlook, By Nervous System Disorders (2021-2030) ($MN)
  • Table 33 Global Multiplex Assays Market Outlook, By Other Clinical Diagnostics (2021-2030) ($MN)
  • Table 34 Global Multiplex Assays Market Outlook, By End User (2021-2030) ($MN)
  • Table 35 Global Multiplex Assays Market Outlook, By Hospitals & Diagnostic Laboratories (2021-2030) ($MN)
  • Table 36 Global Multiplex Assays Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 37 Global Multiplex Assays Market Outlook, By Academic Institutes (2021-2030) ($MN)
  • Table 38 Global Multiplex Assays Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.